{"id":33,"date":"2020-05-07T22:23:01","date_gmt":"2020-05-08T02:23:01","guid":{"rendered":"https:\/\/dnable.wpengine.com\/ct\/?page_id=33"},"modified":"2021-06-10T11:21:25","modified_gmt":"2021-06-10T15:21:25","slug":"study-protocol","status":"publish","type":"page","link":"\/clinicaltrial-03641677\/about-trial\/study-protocol\/","title":{"rendered":"Pivotal Clinical Study Protocol"},"content":{"rendered":"\t\t
The objective of this study is to evaluate the safety and effectiveness of the Centralized Lung Evaluation System (CLES) in enabling evaluation of potential donor lungs not otherwise used for transplant into subjects with end-stage, survival-limiting lung disease in need of lung transplantation. This will be accomplished by evaluating subject survival at the later of 12 months or hospital discharge after transplant.<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
For additional information, please visit
https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03641677<\/a><\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t